DK1305057T3 - Mikropartikelformig biomaterialesammensætning af hyaluronsyre til medicinsk anvendelse - Google Patents

Mikropartikelformig biomaterialesammensætning af hyaluronsyre til medicinsk anvendelse

Info

Publication number
DK1305057T3
DK1305057T3 DK01959403T DK01959403T DK1305057T3 DK 1305057 T3 DK1305057 T3 DK 1305057T3 DK 01959403 T DK01959403 T DK 01959403T DK 01959403 T DK01959403 T DK 01959403T DK 1305057 T3 DK1305057 T3 DK 1305057T3
Authority
DK
Denmark
Prior art keywords
hyaluronic acid
microspheres
utility
properties
microparticulate
Prior art date
Application number
DK01959403T
Other languages
Danish (da)
English (en)
Inventor
Stanley R Conston
Ronald K Yamamoto
Original Assignee
Iscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iscience Corp filed Critical Iscience Corp
Application granted granted Critical
Publication of DK1305057T3 publication Critical patent/DK1305057T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01959403T 2000-07-31 2001-07-31 Mikropartikelformig biomaterialesammensætning af hyaluronsyre til medicinsk anvendelse DK1305057T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62900000A 2000-07-31 2000-07-31
PCT/US2001/024149 WO2002009787A1 (en) 2000-07-31 2001-07-31 Microparticulate biomaterial composition for medical use

Publications (1)

Publication Number Publication Date
DK1305057T3 true DK1305057T3 (da) 2005-10-24

Family

ID=24521177

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01959403T DK1305057T3 (da) 2000-07-31 2001-07-31 Mikropartikelformig biomaterialesammensætning af hyaluronsyre til medicinsk anvendelse

Country Status (8)

Country Link
EP (1) EP1305057B1 (ja)
JP (1) JP2004505065A (ja)
AT (1) ATE298256T1 (ja)
DE (1) DE60111637T2 (ja)
DK (1) DK1305057T3 (ja)
ES (1) ES2244641T3 (ja)
PT (1) PT1305057E (ja)
WO (1) WO2002009787A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
SE0401182D0 (sv) * 2004-05-05 2004-05-05 Q Med Ab Novel use of a viscoelastic composition
US7956180B2 (en) 2004-05-27 2011-06-07 Novozymes A/S Dried and agglomerated hyaluronic acid product
DK1753810T3 (da) * 2004-05-27 2013-11-18 Novozymes Biopharma Dk As Tørret og agglomereret hyaluronsyreprodukt
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
WO2009062254A1 (en) * 2007-11-14 2009-05-22 The University Of Queensland Device and method for preparing microparticles
ITFI20130074A1 (it) * 2013-04-03 2014-10-04 Ambrosone Orazio Soluzione acquosa di contrasto per rendere visibile mediante metodica fotografica il canale di schlemm e le vie di deflusso dell¿umore acqueo e metodo diagnostico che utilizza detta soluzione.
KR20240150530A (ko) 2017-03-22 2024-10-15 아센디스 파마 에이에스 히드로겔 가교된 히알루론산 전구약물 조성물 및 방법
CN114796619B (zh) * 2022-04-14 2023-03-14 珠海麦得发生物科技股份有限公司 可注射透明质酸微球及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733426B1 (fr) * 1995-04-25 1997-07-18 Debacker Yves Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique
US5752974A (en) * 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
FR2759576B1 (fr) * 1997-02-17 1999-08-06 Corneal Ind Implant de sclero-keratectomie pre-descemetique
WO1999011196A1 (en) * 1997-09-04 1999-03-11 Point Biomedical Corporation Injectable tissue reconstruction material
IT1302534B1 (it) * 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per

Also Published As

Publication number Publication date
JP2004505065A (ja) 2004-02-19
ES2244641T3 (es) 2005-12-16
ATE298256T1 (de) 2005-07-15
PT1305057E (pt) 2005-11-30
DE60111637T2 (de) 2006-05-11
WO2002009787A1 (en) 2002-02-07
EP1305057B1 (en) 2005-06-22
EP1305057A1 (en) 2003-05-02
DE60111637D1 (de) 2005-07-28

Similar Documents

Publication Publication Date Title
ES2155043B1 (es) Composiciones farmaceuticas comprendiendo acido pirimidin-5-il(3r, 5s)-3,5-dihidroxihept-6-enoico o una sal suya, su estabilizacion con sal fosfato tribasico y su preparacion.
US9468779B2 (en) Viscoelastic gel for dermatological use
US6960346B2 (en) Vehicles for delivery of biologically active substances
CN104173272B (zh) 一种异硫氰酸酯类化合物的缓释制剂
ATE424848T1 (de) Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
IS2114B (is) Kínasólínafleiður til að meðhöndla æxli
DK1305057T3 (da) Mikropartikelformig biomaterialesammensætning af hyaluronsyre til medicinsk anvendelse
BRPI0409314A (pt) derivados de 2-aminopirimidina e seu uso médico
EA200200431A1 (ru) Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства
HUP0203965A2 (en) Indazole compounds and pharmaceutical compositions containing them
SK12993A3 (en) Pharmaceutical composition of florfenicol
GB0814302D0 (en) Compounds and methods
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
CO5060477A1 (es) Forma de dosificacion de nefazodona
TR200103153T2 (tr) Yeni bileşimler
SE9904413D0 (sv) Comminuted form
ATE424192T1 (de) Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
FR2744452B1 (fr) Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
WO2017131130A1 (ja) コンドロイチン硫酸及びヒアルロン酸を含有する安定化された水性組成物
AP1919A (en) Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same
ATE346592T1 (de) Pharmazeutische zubereitungen mit einem cortisol synthese inhibitor
Taguchi et al. Evaluation of tumor tissue fixation effects of formulation modified Mohs pastes in mice and their water-absorbing properties